Hydra Biosciences
Cambridge, US · Delaware LLC · 1 known investors
Biotech
Founders & leadership
PG
Paul GoldenheimDirector
MM
Magdalene Moran, Ph.D.Executive Officer
BC
Bert Chenard, Ph.D.Executive Officer
VM
Vincent MilesDirector
RH
Russell HerndonExecutive Officer, Director
RC
Robert CarpenterDirector
JG
Jean GeorgeDirector
TB
Tom BurkeExecutive Officer
SE
Steven E. HallDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1raisedJun 2019 · 97 investors · BiotechnologyRule 506(b)
▶$1raisedJun 2019 · 97 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Russell HerndonExecutive Officer, Director
- Robert CarpenterDirector
- Vincent MilesDirector
- Steven HallDirector
- Paul GoldenheimDirector
- Offering amount
- $1
- Amount sold
- $1
- First sale
- May 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$10.5MraisedMar 2015 · 7 investors · BiotechnologyRule 506(b)
▶$10.5MraisedMar 2015 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul GoldenheimDirector
- Magdalene Moran, Ph.D.Executive Officer
- Bert Chenard, Ph.D.Executive Officer
- Vincent MilesDirector
- Russell HerndonExecutive Officer, Director
- Robert CarpenterDirector
- Jean GeorgeDirector
- Tom BurkeExecutive Officer
- Steven E. HallDirector
- Offering amount
- $17.7M
- Amount sold
- $10.5M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.